StockData
XTL Biopharmaceuticals Ltd logo

XTL Biopharmaceuticals Ltd (XTLB) stock

XTLBNasdaqPharmaceutical Preparations
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Jun 30, 2026Score 0/30
$1.62+0.08 (+5.19%)

Close on Nov 17, 2026Market cap $15.33MP/E –Yield –

XTL Biopharmaceuticals market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

XTL Biopharmaceuticals's market cap was $15.71M on Nov 11, 2026, against $29.37M a year earlier. Over the last 5 years it ranged from $15.23M to $63.54M, with a median of $32.26M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$15.71M-23.2%
2025Dec 31, 2025$20.45M-53.7%
2024Dec 31, 2024$44.15M+100.6%
2023Dec 29, 2023$22.02M-16.5%
2022Dec 30, 2022$26.37M-54.9%
2021Dec 31, 2021$58.52M-6.1%
2020Dec 31, 2020$62.32M+121.2%
2019Dec 31, 2019$28.18M-20.8%
2018Dec 31, 2018$35.58M+41.8%
2017Dec 29, 2017$25.09M-25.1%
2016Dec 30, 2016$33.47M–

More XTL Biopharmaceuticals figures

See a number that looks wrong?